The origins of cachexia in acute and chronic inflammatory diseases.
about
Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA bindingImpact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of lifeFunctional role of c-Jun-N-terminal kinase in feeding regulation.Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexiaThe cachexia score (CASCO): a new tool for staging cachectic cancer patients.Mechanisms of fever production and lysis: lessons from experimental LPS fever.The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy.Nutrition modulation of cachexia/proteolysis.Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.Systemic zinc redistribution and dyshomeostasis in cancer cachexia.Body composition and mortality after adult lung transplantation in the United StatesGenomic profiling of host responses to Lassa virus: therapeutic potential from primate to manSystemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2.Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failureCancer cell: using inflammation to invade the host.An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling.Effects of burn injury on markers of hypermetabolism in rats.Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal.Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.Endotoxin and interferon-gamma inhibit translation in skeletal muscle cells by stimulating nitric oxide synthase activityInterleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patientsRel A/p65 is required for cytokine-induced myotube atrophy.HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.Hepatic growth hormone resistance after acute injury.Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.Protein Nutrition and Malnutrition in CKD and ESRD.Nutrition and pancreaticoduodenectomy.When versatility matters: activins/inhibins as key regulators of immunity.Can treating persistent inflammation limit protein energy wasting?Current pharmacotherapy options for cancer anorexia and cachexia.The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool.The immune system's role in sepsis progression, resolution, and long-term outcome.Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.Gene expression in primate liver during viral hemorrhagic fever.
P2860
Q28579041-154E4A8A-2B7C-46ED-BB80-A50A0202F14DQ33598333-CFEE004C-0111-4D2D-9D3C-CE1153E1003CQ33634326-F816D500-26F7-407F-AC83-F7275314040BQ33834933-29824670-A9F1-4DE4-A84B-38C7FC9A9535Q34201322-9D5C9F4D-2842-4306-ABB4-FBB9B6EF8194Q34449816-E6BD6ED0-90F8-4149-9A81-0023939A9CE3Q34516725-79313E01-2710-40B9-BC2B-E291B6C573F3Q34565917-3B560D26-3D3F-4E47-9766-1419792462E1Q34583647-B9A0CE9E-9A1F-48BF-B8EF-183DFCC1109DQ34697225-245C975E-176A-47EF-959D-65801E6D64D3Q34986947-AD097599-E4C3-4BE1-829E-E494AE1611F1Q35248863-86D6EC4E-9902-487A-BDC9-BB489135B425Q35623178-3EE894A2-742D-4434-B483-80DC1330A63FQ35743964-02EE69E9-9959-478B-8BEF-E0A76EE7E438Q35759889-131C88DF-7256-478B-B881-EA43BA8EC28BQ35783526-0FE3C7A4-A072-406E-9F98-2990EFA7EF39Q35826946-B86ABD25-9738-4D20-A719-746863E29033Q35845226-58BD164A-F8BD-40E9-A059-019AA708010FQ35860923-65128B90-CE61-4D82-B779-573F34ADD2EAQ35868276-5BA4374C-1389-47B3-823E-165C04A799A7Q35880345-182B7E3B-003B-4D09-9033-3847BE247A7AQ35893437-FBCF6E51-CDE7-44F3-9A06-B694B259FE28Q36114658-E0B4F334-D7FA-4B0E-A05B-8EFFA33EBA05Q36603504-EC348679-694F-4FFA-9F56-60EC06D05574Q36699521-BE0CFD6D-1842-4427-A0DE-5713F4E93E19Q36705832-53F62649-CD42-4BB7-9471-4E6878C5C003Q37103603-47AC7A99-9F1D-4597-BB3D-AD9C159A167BQ37154729-6E079284-9207-4B69-BEC4-3D9A18BB78A3Q37313761-487DD8B8-249B-46E3-ABC4-C588067AA316Q37729646-321D6CE7-71C4-44B0-9377-5AE64F3D2143Q37767970-F01899F9-EA31-42EA-978D-BE6188541B95Q37871336-FA085003-BB89-4FF7-B161-C659ECC1261CQ38050186-62FD74C7-343F-48BC-9B5A-1BB5595A20EAQ38052613-6FB186B5-EC0B-41E3-AB8A-25D5D6FF4D54Q38586078-95B5893C-539B-4C40-A43F-70B39FE484FEQ38842194-A11B697E-3966-4EED-9FB5-6AEC4AA75FA8Q38928547-E49369F4-F6E3-449B-900E-B7F2EC526FA4Q38991057-153038D2-C12D-4875-9A36-BFF9D5456B6DQ39728443-73C6EC74-BFF9-451D-A85D-E2F030E79477Q40397175-6F503DB3-9760-46EF-B59B-7596395A0261
P2860
The origins of cachexia in acute and chronic inflammatory diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The origins of cachexia in acute and chronic inflammatory diseases.
@ast
The origins of cachexia in acute and chronic inflammatory diseases.
@en
type
label
The origins of cachexia in acute and chronic inflammatory diseases.
@ast
The origins of cachexia in acute and chronic inflammatory diseases.
@en
prefLabel
The origins of cachexia in acute and chronic inflammatory diseases.
@ast
The origins of cachexia in acute and chronic inflammatory diseases.
@en
P2860
P1476
The origins of cachexia in acute and chronic inflammatory diseases
@en
P2093
Lyle L Moldawer
P2860
P356
10.1177/011542650602100168
P577
2006-02-01T00:00:00Z